Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes

ISSN： 1357-0560

Source： Medical Oncology, Vol.23, Iss.1, 2006-03, pp. : 37-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes

By Ma Xiaomei

Cancer Causes and Control, Vol. 22, Iss. 4, 2011-04 ,pp. : 623-629

Springer Publishing Company

Access to resources Recommend Favorite

Risk factors for myelodysplastic syndromes: a case–control study in Greece

By Dalamaga M.

Cancer Causes and Control, Vol. 13, Iss. 7, 2002-09 ,pp. : 603-608

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of epidemiological factors in survival of patients with de novo myelodysplastic syndromes

By Elhor Gbito Kplola Garcia-Manero Guillermo Strom Sara

Cancer Causes and Control, Vol. 25, Iss. 4, 2014-04 ,pp. : 425-435

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Strategies in Myelodysplastic Syndromes

By Atallah Ehab Garcia-Manero Guillermo

Cancer Investigation, Vol. 26, Iss. 2, 2008-02 ,pp. : 208-216

Informa Healthcare

Access to resources Recommend Favorite

Azacitidine in Lower‐Risk Myelodysplastic Syndromes: A Meta‐Analysis of Data from Prospective Studies

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 159-170

John Wiley & Sons Inc

Access to resources Recommend Favorite